It was demonstrated that siRNA treatment in ADLD fibroblasts, murine oligodendrocytes overexpressing LMNB1, and reprogrammed neurons from patient fibroblasts effectively abrogated the ADLD-specific phenotype and therefore suggested a possible therapeutic strategy. The gene discussed is LMNB1; the disease is adult-onset autosomal dominant demyelinating leukodystrophy.